Cancer Imaging Systems Market Size, Share, Growth, Analysis, Trend, and Forecast Research Report by 2027

Emergen Research Logo

Emergen Research Logo

The increasing incidence of cancer is one of the significant factors influencing the market growth.

VANCOUVER, BC, CANADA, October 26, 2021 /EINPresswire.com/ -- The global cancer imaging systems market is projected to be worth USD 12.24 Billion by 2027, according to a current analysis by Emergen Research. The Global Cancer Imaging Systems Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Cancer Imaging Systems market in each key region of the world. The market evaluations over the forecast years are based on a comprehensive analysis of the leading market segments, such as product type outlook, application continuum, regional overview, and competitive landscape of the global Cancer Imaging Systems market. The cancer imaging systems market is observing high demand attributed to the increasing incidence of cancer. Cancer significantly impacts the societal and economic growth in the US and worldwide and is a major contributor to the cost burden of disease. It has been anticipated that 1,806,590 new cancer cases are likely to be diagnosed in the US in 2020, and 606,520 deaths will occur owing to the disease.

Growing technological advancements and increased investments in cancer imaging are causative of the rapid growth of the market. Hologic, Inc., in November 2019, received approval from the US Food and Drug Administration (FDA) for its 3DQuorum™ Imaging Technology, driven by Genius AI™. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth of the market. The Global Cancer Imaging Systems Market Report offers extensive knowledge and information about the Cancer Imaging Systems market pertaining to market size, market share, growth influencing factors, opportunities, and current and emerging trends.

To get a sample copy of the Global Cancer Imaging Systems Market report, visit @ https://www.emergenresearch.com/request-sample/222

The technology works simultaneously with Hologic’s Clarity HD™ high-resolution imaging technology and helps radiologists reduce tomosynthesis image volume by 66.0%. The breast imaging system owing to such advancements would produce higher-resolution 3D images, better workflow, and an improved mammography experience for patents necessitating low radiation dose.

Key Highlights From The Report

In July 2019, Agilent Technologies Inc. made an announcement about the signing of an agreement to buy BioTek Instruments, a private firm, for USD 1.17 billion. BioTek is involved in designing, producing, and distributing groundbreaking life science instrumentation, including cell imaging systems.

MRI offers the benefit of imaging soft body tissue parts that are occasionally hard to view using other types of modalities. MRI is excellent at identifying and locating some cancers. Moreover, an MRI deploying contrast dye is the most appropriate brain and spinal cord tumor imaging technique.

Key participants include GE Healthcare, Hitachi Medical, Becton, Dickinson, and Company, Thermo Fisher Scientific Inc., CR Bard Inc., Agilent Technologies, Abbott, Illumina Inc., Roche, and Philips Healthcare, among others.
To learn more details about the Global Cancer Imaging Systems Market report, visit @ https://www.emergenresearch.com/industry-report/cancer-imaging-systems-market

Global Cancer Imaging Systems Market Report - Segmental Analysis:

The global Cancer Imaging Systems business vertical has been extensively categorized on the basis of product type, application gamut, end-user industries, and a competitive overview. The report inspects the current market scenario, its past performance, demand and supply ratios, production and consumption rates, sales, and numerous growth opportunities available in the market. It further estimates the prospective growth of the leading regional segments of the market, which is beneficial for readers to gain impactful insights into the Cancer Imaging Systems business sector. A clear outline of the competitive landscape of the market is expected to help businesses involved in this sector decipher the optimal business moves to reach their desired business goals.

Product Type Segmentation:

Emergen Research has segmented the global cancer imaging systems market on the basis of imaging systems, application, end-users, and region:
Imaging Systems Outlook (Revenue, USD Billion; 2017-2027)
Mammography
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Positron Emission Tomography (PET)
Others

Application Outlook (Revenue, USD Billion; 2017-2027)
Breast Cancer
Lung Cancer
Colorectal Cancer
Melanoma
Others

End-Users Outlook (Revenue, USD Billion; 2017-2027)
Hospitals & Clinics
Diagnostic Centers
Others

The report aims to deliver a comprehensive understanding of the Cancer Imaging Systems market growth and expansion in each key region of the world. It offers accurate estimations about the expected market size and growth over the projected timeline of 2020-2027.

Key Geographies Profiled in the Report:
North America(the U.S., Mexico, and Canada)
Asia Pacific(China, Japan, India, and Rest of Asia Pacific)
Europe(the U.K., France, Germany, and Rest of Europe)
Latin America(Brazil and Rest of Latin America)
Middle East & Africa(GCC Countries and Rest of Middle East & Africa)

Proceed To Buy: https://www.emergenresearch.com/select-license/222
Table of Content

Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique

Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Cancer Imaging Systems Market Segmentation & Impact Analysis
4.1. Cancer Imaging Systems Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing incidence of cancer
4.2.2.2. Rising government initiatives to spread cancer awareness
4.2.2.3. Increase in healthcare expenditure
4.2.2.4. Development of new biomarkers
4.2.3. Market restraints analysis
4.2.3.1. Cost prohibitive imaging systems
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis

Chapter 5. Cancer Imaging Systems Market By Imaging Systems Insights & Trends, Revenue (USD Million)
5.1. Imaging Systems Dynamics & Market Share, 2019 & 2027
5.1.1. Mammography
5.1.2. Computed Tomography (CT)
5.1.3. Magnetic Resonance Imaging (MRI)
5.1.4. Ultrasound
5.1.5. Positron Emission Tomography (PET)
5.1.6. Others
Continue...

Key Questions Answered in the Report:

What is the growth rate of the Cancer Imaging Systems market? What is the anticipated market valuation of Cancer Imaging Systems industry by 2027?

What are the key growth driving and restraining factors of the Cancer Imaging Systems market?

Who are the prominent players operating in the market? What are the key strategies adopted by these companies?

Key Objectives of the Global Cancer Imaging Systems Market Report:

An all-inclusive analysis and forecast estimation of the market have been included in this report.

The report offers valuable insights into the major drivers, limitations, opportunities, and challenges faced by the global Cancer Imaging Systems market and its leading players.

The report sheds light on the prominent market contenders, as well as their business strategies and long-term expansion plans.

To get a discount on the Global Cancer Imaging Systems Market report, visit @ https://www.emergenresearch.com/request-discount/222

Thank you for reading our report. If you have any requests for customization of the latest report, kindly get in touch with us. Our team will assist you and ensure the report is designed as per your requirements.

Read similar reports by Emergen Research:
Nucleic Acid Isolation and Purification Market: https://www.emergenresearch.com/industry-report/nucleic-acid-isolation-and-purification-market

Viral Vector and Plasmid Manufacturing Market: https://www.emergenresearch.com/industry-report/viral-vector-and-plasmid-manufacturing-market

Interoperability Solutions in Healthcare Market: https://www.emergenresearch.com/industry-report/interoperability-solutions-in-healthcare-market

Newborn Screening Market: https://www.emergenresearch.com/industry-report/new-born-screening-market

RFID in Healthcare Market: https://www.emergenresearch.com/industry-report/rfid-in-healthcare-market

Next-Generation Sequencing Market: https://www.emergenresearch.com/industry-report/next-generation-sequencing-market

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Eric Lee
Emergen Research
+91 90210 91709
sales@emergenresearch.com
Visit us on social media:
Facebook
Twitter
LinkedIn